Age-Stratified Sex Differences in Heart Failure With Preserved Ejection Fraction Among Adult Hospitalizations.
Journal
The Journal of cardiovascular nursing
ISSN: 1550-5049
Titre abrégé: J Cardiovasc Nurs
Pays: United States
ID NLM: 8703516
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
medline:
11
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
There is evidence that heart failure with preserved ejection fraction (HFpEF)-related hospitalizations are increasing in the United States. However, there is a lack of knowledge about HFpEF-related hospitalizations among younger adults. The aims of this study were to perform a retrospective analysis using the Nationwide Inpatient Sample and to examine age-stratified sex differences in the prevalence, correlates, and outcomes of HFpEF-related hospitalization across the adult life span. Using the Nationwide Inpatient Sample (2002-2014), patient and hospital characteristics were determined. Joinpoint regression was used to describe age-stratified sex differences in the annual average percent change of hospitalizations with HFpEF. Survey logistic regression was used to estimate adjusted odds ratios representing the association of sex with HFpEF-related hospitalization and in-hospital mortality. There were 8 599 717 HFpEF-related hospitalizations (2.43% of all hospitalizations). Women represented the majority (5 459 422 [63.48%]) of HFpEF-related adult hospitalizations, compared with men (3 140 295 [36.52%]). Compared with men younger than 50 years, women within the same age group were 6% to 28% less likely to experience HFpEF-related hospitalization. Comorbidities such as hypertensive heart disease, renal disease, hypertension, obstructive sleep apnea, atrial fibrillation, obesity, anemia, and pulmonary edema explained a greater proportion of the risk of HFpEF-related hospitalization in adults younger than 50 years than in adults 50 years or older. Before the age of 50 years, women exhibit lower HFpEF-related hospitalization than men, a pattern that reverses with advancing age. Understanding and addressing the factors contributing to these sex-specific differences can have several potential implications for improving women's cardiovascular health.
Sections du résumé
BACKGROUND
BACKGROUND
There is evidence that heart failure with preserved ejection fraction (HFpEF)-related hospitalizations are increasing in the United States. However, there is a lack of knowledge about HFpEF-related hospitalizations among younger adults.
OBJECTIVE
OBJECTIVE
The aims of this study were to perform a retrospective analysis using the Nationwide Inpatient Sample and to examine age-stratified sex differences in the prevalence, correlates, and outcomes of HFpEF-related hospitalization across the adult life span.
METHOD
METHODS
Using the Nationwide Inpatient Sample (2002-2014), patient and hospital characteristics were determined. Joinpoint regression was used to describe age-stratified sex differences in the annual average percent change of hospitalizations with HFpEF. Survey logistic regression was used to estimate adjusted odds ratios representing the association of sex with HFpEF-related hospitalization and in-hospital mortality.
RESULTS
RESULTS
There were 8 599 717 HFpEF-related hospitalizations (2.43% of all hospitalizations). Women represented the majority (5 459 422 [63.48%]) of HFpEF-related adult hospitalizations, compared with men (3 140 295 [36.52%]). Compared with men younger than 50 years, women within the same age group were 6% to 28% less likely to experience HFpEF-related hospitalization. Comorbidities such as hypertensive heart disease, renal disease, hypertension, obstructive sleep apnea, atrial fibrillation, obesity, anemia, and pulmonary edema explained a greater proportion of the risk of HFpEF-related hospitalization in adults younger than 50 years than in adults 50 years or older.
CONCLUSION
CONCLUSIONS
Before the age of 50 years, women exhibit lower HFpEF-related hospitalization than men, a pattern that reverses with advancing age. Understanding and addressing the factors contributing to these sex-specific differences can have several potential implications for improving women's cardiovascular health.
Identifiants
pubmed: 38200643
doi: 10.1097/JCN.0000000000001069
pii: 00005082-990000000-00163
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Savarese G, D'Amario D. Sex differences in heart failure. Adv Exp Med Biol. 2018;1065:529–544. doi:10.1007/978-3-319-77932-4_32.
doi: 10.1007/978-3-319-77932-4_32
Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602. doi:10.1038/nrcardio.2017.65.
doi: 10.1038/nrcardio.2017.65
Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–2486. doi:10.1016/j.jacc.2017.08.0741.
doi: 10.1016/j.jacc.2017.08.0741
Jain V, Minhas AMK, Morris AA, et al. Demographic and regional trends of heart failure-related mortality in young adults in the US, 1999–2019. JAMA Cardiol. 2022;7(9):900–904. doi:10.1001/jamacardio.2022.2213.
doi: 10.1001/jamacardio.2022.2213
Briller JE, Mogos MF, Muchira JM, Piano MR. Pregnancy associated heart failure with preserved ejection fraction: risk factors and maternal morbidity. J Card Fail. 2021;27(2):143–152. doi:10.1016/j.cardfail.2020.12.020.
doi: 10.1016/j.cardfail.2020.12.020
Goyal P, Almarzooq ZI, Horn EM, et al. Characteristics of hospitalizations for heart failure with preserved ejection fraction. Am J Med. 2016;129(6):635.e15–635.e26. doi:10.1016/j.amjmed.2016.02.007.
doi: 10.1016/j.amjmed.2016.02.007
Goyal P, Paul T, Almarzooq ZI, et al. Sex- and race-related differences in characteristics and outcomes of hospitalizations for heart failure with preserved ejection fraction. J Am Heart Assoc. 2017;6(4):e003330. doi:10.1161/jaha.116.003330.
doi: 10.1161/jaha.116.003330
Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848–3855. doi:10.1093/eurheartj/ehz136.
doi: 10.1093/eurheartj/ehz136
Admon LK, Ford ND, Ko JY, et al. Trends and distribution of in-hospital mortality among pregnant and postpartum individuals by pregnancy period. JAMA Netw Open. 2022;5(7):e2224614. doi:10.1001/jamanetworkopen.2022.24614.
doi: 10.1001/jamanetworkopen.2022.24614
Hirai AH, Owens PL, Reid LD, Vladutiu CJ, Main EK. Trends in severe maternal morbidity in the US across the transition to ICD-10-CM/PCS from 2012–2019. JAMA Netw Open. 2022;5(7):e2222966. doi:10.1001/jamanetworkopen.2022.22966.
doi: 10.1001/jamanetworkopen.2022.22966
Cooper LB, Psotka MA, Sinha S, et al. Specificity of administrative coding for older adults with acute heart failure hospitalizations. Am Heart J. 2020;223:1–2. doi:10.1016/j.ahj.2020.02.004.
doi: 10.1016/j.ahj.2020.02.004
Healthcare Cost and Utilization Project (HCUP). Introduction to the HCUP National Inpatient Sample (NIS) 2013. https://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2013.jsp. Accessed May 5, 2020
DeShazo JP, Hoffman MA. A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample. BMC Health Serv Res. 2015;15:384. doi:10.1186/s12913-015-1025-7.
doi: 10.1186/s12913-015-1025-7
Healthcare Cost and Utilization Project (HCUP). Trend Weights for HCUP NIS Data. Rockville, MD: Agency for Healthcare Research and Quality; 2015. www.hcup-us.ahrq.gov/db/nation/nis/trendwghts.jsp. Accessed May 5, 2020, 2020.
Pearce N. Analysis of matched case-control studies. BMJ. 2016;352:i969. doi:10.1136/bmj.i969.
doi: 10.1136/bmj.i969
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(sici)1097-0258(20000215)19:3 < 335:aid-sim336 > 3.0.co;2-z.
doi: 10.1002/(sici)1097-0258(20000215)19:3
Bozkurt B, Khalaf S. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017;13(4):216–223. doi:10.14797/mdcj-13-4-216.
doi: 10.14797/mdcj-13-4-216
Regitz-Zagrosek V. Sex and gender differences in heart failure. Int J Heart Fail. 2020;2:157–181.
Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424–1431. doi:10.1093/eurheartj/eht066.
doi: 10.1093/eurheartj/eht066
Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3(1):7–11. doi:10.15420/cfr.2016:25:2.
doi: 10.15420/cfr.2016:25:2
Tromp J, Paniagua SMA, Lau ES, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. BMJ. 2021;372:n461. doi:10.1136/bmj.n461.
doi: 10.1136/bmj.n461
Ziaeian B, Kominski GF, Ong MK, Mays VM, Brook RH, Fonarow GC. National differences in trends for heart failure hospitalizations by sex and race/ethnicity. Circ Cardiovasc Qual Outcomes. 2017;10(7):e003552. doi:10.1161/circoutcomes.116.003552.
doi: 10.1161/circoutcomes.116.003552
Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012;126(1):65–75. doi:10.1161/circulationaha.111.080770.
doi: 10.1161/circulationaha.111.080770
US Census Bureau. U.S.—seniors as a percentage of the population 1950–2050. https://www.statista.com/statistics/457822/share-of-old-age-population-in-the-total-us-population/#:~:text=In%202017%2C%20about%2016%20percent,population%20was%2065%20or%20over. Accessed June 2, 2020.
Mohammed SF, Borlaug BA, Roger VL, et al. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail. 2012;5(6):710–719. doi:10.1161/circheartfailure.112.968594.
doi: 10.1161/circheartfailure.112.968594
Moore KJ. New ICD-9 codes take effect this month. Fam Pract Manag. 2002;9(9):21–22.
Patel H, Aggarwal NT, Rao A, et al. Microvascular disease and small-vessel disease: the nexus of multiple diseases of women. J Womens Health (Larchmt). 2020;29(6):770–779. doi:10.1089/jwh.2019.7826.
doi: 10.1089/jwh.2019.7826
Keshvani N, Shah S, Ayodele I, et al. Sex differences in long-term outcomes following acute heart failure hospitalization: findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail. 2023;25(9):1544–1554. doi:https://doi.org/10.1002/ejhf.3003.
doi: 10.1002/ejhf.3003
Scantlebury DC, Borlaug BA. Why are women more likely than men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol. 2011;26(6):562–568. doi:10.1097/HCO.0b013e32834b7faf.
doi: 10.1097/HCO.0b013e32834b7faf
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–259. doi:10.1056/NEJMoa052256.
doi: 10.1056/NEJMoa052256
Loh JC, Creaser J, Rourke DA, et al. Temporal trends in treatment and outcomes for advanced heart failure with reduced ejection fraction from 1993–2010: findings from a university referral center. Circ Heart Fail. 2013;6(3):411–419. doi:10.1161/circheartfailure.112.000178.
doi: 10.1161/circheartfailure.112.000178
Rich JD, Burns J, Freed BH, Maurer MS, Burkhoff D, Shah SJ. Meta-Analysis Global Group in Chronic (MAGGIC) heart failure risk score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction. J Am Heart Assoc. 2018;7(20):e009594. doi:10.1161/jaha.118.009594.
doi: 10.1161/jaha.118.009594
Sabbatini AR, Kararigas G. Menopause-related estrogen decrease and the pathogenesis of HFpEF: JACC review topic of the week. J Am Coll Cardiol. 2020;75(9):1074–1082. doi:10.1016/j.jacc.2019.12.049.
doi: 10.1016/j.jacc.2019.12.049